GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cronos Group Inc (TSX:CRON) » Definitions » Cyclically Adjusted Price-to-FCF

Cronos Group (TSX:CRON) Cyclically Adjusted Price-to-FCF : (As of May. 22, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Cronos Group Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cronos Group Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Cronos Group's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cronos Group Cyclically Adjusted Price-to-FCF Chart

Cronos Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cronos Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cronos Group's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Cronos Group's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cronos Group's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cronos Group's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Cronos Group's Cyclically Adjusted Price-to-FCF falls into.



Cronos Group Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Cronos Group's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Cronos Group's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.015/126.2576*126.2576
=-0.015

Current CPI (Mar. 2024) = 126.2576.

Cronos Group Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.001 99.473 -0.001
201409 -0.007 99.394 -0.009
201412 0.000 98.367 0.000
201503 -0.027 99.789 -0.034
201506 -0.017 100.500 -0.021
201509 -0.023 100.421 -0.029
201512 -0.011 99.947 -0.014
201603 -0.019 101.054 -0.024
201606 -0.026 102.002 -0.032
201609 -0.046 101.765 -0.057
201612 -0.024 101.449 -0.030
201703 -0.032 102.634 -0.039
201706 -0.042 103.029 -0.051
201709 -0.064 103.345 -0.078
201712 -0.179 103.345 -0.219
201803 -0.137 105.004 -0.165
201806 -0.174 105.557 -0.208
201809 -0.267 105.636 -0.319
201812 -0.109 105.399 -0.131
201903 -0.118 106.979 -0.139
201906 -0.196 107.690 -0.230
201909 -0.132 107.611 -0.155
201912 -0.196 107.769 -0.230
202003 -0.173 107.927 -0.202
202006 -0.187 108.401 -0.218
202009 -0.138 108.164 -0.161
202012 -0.176 108.559 -0.205
202103 -0.186 110.298 -0.213
202106 -0.137 111.720 -0.155
202109 -0.115 112.905 -0.129
202112 -0.125 113.774 -0.139
202203 -0.117 117.646 -0.126
202206 -0.065 120.806 -0.068
202209 -0.053 120.648 -0.055
202212 -0.090 120.964 -0.094
202303 -0.174 122.702 -0.179
202306 -0.043 124.203 -0.044
202309 -0.002 125.230 -0.002
202312 0.053 125.072 0.054
202403 -0.015 126.258 -0.015

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cronos Group  (TSX:CRON) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Cronos Group Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Cronos Group's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Cronos Group (TSX:CRON) Business Description

Industry
Traded in Other Exchanges
Address
111 Peter Street, Suite 300, Toronto, ON, CAN, M5V 2H1
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
Executives
Michael Ernest Coates Director